HSBC analyst Frank Lee just upgraded Advanced Micro Devices (AMD) from “Hold” to “Buy,” doubling its price target from $100 to $200 per share, implying a 44.5% upside from the stock’s closing price of ...

As the investing landscape evolves at breakneck speed, two online brokerage giants — Robinhood Markets HOOD and Charles Schwab SCHW — stand at the forefront of a financial transformation targeting ...

On July 8, 2025, trading in Chipotle call options exploded, with volume soaring to a level 145.8% above its daily average.

Traders have repeatedly shrugged off President Trump’s disruptive tariff wars and fiscal policy, pushing U.S. stock prices ...

BNP's strategy note "Running It Hot" predicts the S&P 500 at 6,700 12 months out, with Eurostoxx 600 rising to 590.

Discover how Citadel Securities solidifies its dominance in market-making with a key acquisition from Morgan Stanley.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Meta’s $100 million sign-up bonuses have underscored the value of cutting-edge tech talent. Indian businesses should also be ...

Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...

After Glenmark’s landmark $2 billion licensing deal with US major AbbVie for its cancer drug, ISB 2001, the stock hit the 10% ...

The licensing deal is the largest one by any Indian pharma company, and the deal value is above expectations, said Nomura.